Skip to content

Driving pressure during general anesthesia for minimally invasive abdominal surgery - a randomized clinical trial

Driving pressure during general anesthesia for minimally invasive abdominal surgery - a randomized clinical trial - GENERATOR

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56378
Enrollment
1445
Registered
2023-05-30
Start date
2023-12-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung complications after surgery Postoperative pulmonary complications Lung complications after surgery

Interventions

An individualized high PEEP with recruitment maneuvers ventilation strategy, targeting a low driving pressure will be compared to a standard low PEEP without recruitment maneuvers during intraoperat

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this trial, a patient must meet the following criteria: 1. age above 18 years; 2. scheduled for minimally invasive abdominal surgery; AND 3. increased (i.e., intermediate or high) risk of PPCs according to the ARISCAT risk score (26 or more points); OR 4. the combination of age above 40 years, scheduled surgery lasting more than 2 hours and planned to receive an intra-arterial catheter for blood pressure monitoring during the surgery; 5. signed written informed consent

Exclusion criteria

Exclusion criteria: A potential patient who meets any of the following criteria will be excluded from participation in this trial: 1. planned for open abdominal surgery; 2. planned for surgery in lateral or prone position; 3. planned for combined abdominal and intra-thoracic surgery 4. confirmed pregnancy; 5. consent for another interventional trial during anesthesia; 6. having received invasive ventilation > 30 minutes within the last five days; 7. any previous lung surgery; 8. history of previous severe chronic obstructive pulmonary disease (COPD) with (noninvasive) ventilation or oxygen therapy at home or repeated systemic corticosteroid therapy for acute exacerbations of COPD; 9. history of acute respiratory distress syndrome (ARDS); 10. expected to require postoperative ventilation; 11. expected hemodynamic instability or intractable shock; 12. severe cardiac disease (New York Heart Association class III or IV, acute coronary syndrome or persistent ventricular tachyarrhythmia*s).

Design outcomes

Primary

MeasureTime frame
The primary outcome is a composite of PPCs in the first 5 postoperative days - Mild respiratory failure - Severe respiratory failure - Bronchospasm - Pneumonia - Aspiration pneumonitis - Atelectasis - Acute respiratory distress syndrome (ARDS) - Pleural effusion - Cardiopulmonary edema - Pneumothorax

Secondary

MeasureTime frame
Intraoperative complications including: - Desaturation - Hypotension - Increased need for vasoactive medications - New arrhytmias needing intervention Impaired wound healing Postoperative extrapulmonary complications - Sepsis - Septic shock - Extra-pulmonary infection - Acute renal insufficiency Impaired wound healing Intra-operative fluid strategy All cause mortality at day 5, 30 and 90 Cost-effectiveness variables - Postoperative supplementary oxygen need - Use of antibiotics for pneumonia - Need for thoracic imaging - Length of hospital stay - Need of ICU admission and corresponding lenth of ICU stay - Unplanned admission to an intenvise care unit (ICU) and lenght of stay on ICU - Length of hospital stay

Countries

Austria, Germany, Italy, Netherlands, Spain

Contacts

Public ContactM.W. Hollmann

Amsterdam UMC

m.w.hollmann@amsterdamumc.nl0205662533

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026